Work

Phase I Clinical Trial of Ds-7423, an Oral Pi3K/Mtor Dual Inhibitor, in Japanese Patients with Advanced Solid Tumors

Year: 2014

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdu331.20

Authors: T. Yokota, T. Tsushima, H. Kenmotsu, J. Watanabe, M. Endo, Y. Hirashima, T. Takahashi, H. Murakami, T. Naito, T. Taira, A. Ono, K. Wakuda, A. Todaka, K. Kunieda, T. Jikoh, Y. Nakao, R. Shiga, H. Yasui

Institutions: Shizuoka Cancer Center, Daiichi-Sankyo (Japan)

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2104243174

FWCI: 0.11

Cites:

Cited by: 2

Related to: 10